EGFR and neoplasm: In addition, depending on the genotype of the tumor and its location, antibodies targeting the vascular endothelial growth factor (such as bevacizumab) or epidermal growth factor receptor (such as cetuximab) are added to the chemotherapy regimen [4,5].